Physician profile
John Chin
NPI 1134291206
$182,153.41
in general payments reported to CMS, 2019-2025
20 companies · $16.46 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97K · 2020: $27K · 2021: $18K · 2022: $18K · 2023: $23K · 2024: $19.65 · 2025: $16.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Travel and Lodging: $1,076 · Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,585.00 |
| Travel and Lodging | $1,075.92 |
| Food and Beverage | $290.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $104,547.07 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $33,304.54 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $28,063.70 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4,127.86 | 2019-2022 | |
| Akcea Therapeutics, INC. | $2,707.96 | 2019-2020 | |
| Vifor Pharma, INC. | $2,652.56 | 2019-2021 | |
| Amgen INC. | $2,405.60 | 2019-2020 | |
| Abbott Laboratories | $1,663.66 | 2019-2021 | |
| Biotronik INC. | $896.81 | 2019-2020 | |
| Pfizer INC. | $719.49 | 2019-2020 | |
| Abiomed | $248.44 | 2019-2021 | |
| Medtronic Vascular, INC. | $220.00 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $189.98 | 2019-2021 | |
| Portola Pharmaceuticals, LLC | $127.45 | 2019 | |
| Boston Scientific Corporation | $122.35 | 2019-2025 | Avvigo Guidance System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acist Medical Systems, INC. | $78.21 | 2019 | |
| Heartflow, INC. | $55.27 | 2019 | |
| Daiichi Sankyo INC. | $19.76 | 2019 | |
| Janssen Scientific Affairs, LLC | $2.70 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Chin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.